Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling

Journal of Hepatology

Volumn 22, Issue 1, 1995, Pages 43-49

  Rudi, Jochen ^a   Waldherr, Rüdger ^a   Raedsch, Richard ^b   Kommerell, Burkhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b ST JOSEFS HOSPITAL   (Germany)

Author keywords

Hepatocyte proliferations; Ki 67; Primary biliary cirrhosis; Proliferating cell nuclear antigen

Indexed keywords

CELL NUCLEUS ANTIGEN;

ARTICLE; BILIARY CIRRHOSIS; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL;

CELL DIVISION; FEMALE; FOLLOW-UP STUDIES; HUMAN; KI-67 ANTIGEN; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; URSODEOXYCHOLIC ACID;

EID: 0028883166     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8278(95)80258-4     Document Type: Article

References (55)

1. Primary biliary cirrhosis (chronic intrahepatic obstructive jaundice)
2. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cholangitis)
3. Increased uptake of bromodeoxyuridine by hepatocytes from early stage of primary biliary cirrhosis
4. Assessment of cell proliferation in histological material
5. Identification of a nuclear and of a cytoplasmatic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation
6. Identity of the proliferating cell nuclear antigen and cyclin
7. Cyclin/PCNA is the auxiliary protein of DNA polymerase δ
8. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein
9. Regulation of proliferating cell nuclear antigen during the cell cycle
10. Characterization of proliferating cell nuclear antigan recognized by autoantibodies in lupus sera
11. Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA/cyclin
12. Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues
13. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues
14. Proliferating cell nuclear antigen (PCNA/cyclin) immunocytochemistry as a labelling index in mouse lung tissues
15. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms
16. Immunohistochemical markers of cellular proliferation: achievements, problems and prospects
17. Immunocytochemical identification of proliferative hepatocytes using monoclinal antibody to proliferating cell nuclear antigen (PCNA/cyclin). Comparison with immunocytochemical staining for DNA polymerase-alpha
18. Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver diseases fixed in formaldehyde
19. Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: a study of proliferating cell nuclear antigen expression
20. Proliferating cell nuclear antigen immunolocalization in gastro-intestinal epithelia
21. Proliferation cell nuclear antigen (clone 19A2) correlates with 5-bromo-2-deoxyuridine labelling in human colonic epithelium
22. Immunocytochemical identification of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen
23. Production of a mouse monoclonal antibody reactive with human nuclear antigen associated with cell proliferation
24. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
25. Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells
26. The cell proliferation-associated antigen of antibody Ki-67 a very large ubiquitous nuclear protein with numerous repeated elements representing a new kind of cell cycle-maintaining proteins
27. Cell-cycle-related staining pattern of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining
28. Proliferating cell nuclear antigen in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue
29. Thymidine labeling index and Ki-67 growth fraction in lesions of the breast
30. Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors
31. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
32. Detection of Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB 1
33. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis
34. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial
35. Einfluß der Ursodesoxycholsäure-Behandlung auf die unterschiedlichen Erkrankungsstadien der primär biliären Zirrhose
36. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis
37. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form
38. PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines
39. Clinicopathological study of proliferating cell nuclear antigen (PCNA) of hepatocytes in primary biliary cirrhosis
40. Clinical application of morphologic and immunocytochemical assessments of cell proliferation
41. The relevance of antibody concentration to the immunohistochemical quantification of cell proliferation-associated antigens
42. Intrahepatic bile duct damage in various forms of liver disease
43. Histologische Diagnostik der primären biliären Zirrhose (PBC)
44. Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes
45. Receptors for epidermal growth factor (urogastrone) and insulin in primary cultures of rat hepatocytes maintained in serum-free medium
46. Native and recombinant human hepatocyte growth factors are highly potent promotors of DNA synthesis in both human and rat hepatocytes
47. Hepatocyte growth factor - how do I know thee? Let me count the ways
48. Hepatic growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration
49. Structure and function of hepatocyte growth factor
50. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis
51. Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to III
52. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat
53. Hepatic expression of class I and II major histocompatibility complex molecules in primary biliary cirrhosis. Effect of ursodeoxycholic acid
54. Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in primary biliary cirrhosis